Mechanism of action
The effect of Midazolam is mediated by the stimulation of benzodiazepine receptors in the central nervous system.
The drug causes allosteric modulation of GABA receptors, which leads to increased sensitivity of $ ext{GABA}_ ext{A}$ receptors to the main inhibitory neurotransmitter — gamma-aminobutyric acid (GABA). As a result, the frequency of chloride channel opening increases. Chloride ions ($Cl^-$) massively enter the cell, causing neuronal membrane hyperpolarization. The culmination of this cascade is the development of pronounced inhibitory processes in the CNS.
Classification and pharmacokinetics
Among benzodiazepine derivatives, drugs are categorized by the duration of their therapeutic effect. Midazolam (along with triazolam) belongs to short-acting drugs.
Its half-life ($t_{1/2}$) is only 1–5 hours. For comparison: intermediate-acting drugs (nitrazepam, phenazepam) act for 12–40 hours, and long-acting ones (diazepam, flurazepam) from 40 to 250 hours. Due to the short $t_{1/2}$, midazolam does not accumulate in the body and has negligible hangover effects.
Pharmacological effects and indications
The main pharmacological effects of the drug are hypnotic and sedative (the latter manifests when used in low doses).
In clinical practice, Midazolam is prescribed in two main situations:
- As a hypnotic (per os): the drug is prescribed primarily to facilitate sleep onset in insomnia.
- In anesthesiology: used for premedication before surgical procedures (administered orally or intramuscularly), as well as for anesthesia induction (administered intravenously).
Risks and drug interactions
Dangers of parenteral administration: When administered intravenously (especially rapidly), there is a high risk of respiratory depression, up to complete respiratory arrest.
Metabolism: Midazolam is a substrate for the largest group of hepatic enzymes — the CYP3A4 / CYP3A5 isoenzymes. This requires strict monitoring when co-prescribed with other drugs:
- CYP3A4 inhibitors slow down the degradation of midazolam, increasing its toxicity. These include azoles (ketoconazole, metronidazole), macrolides (erythromycin, clarithromycin), ciprofloxacin, cardiovascular drugs (verapamil, diltiazem, quinidine), ritonavir, and dietary inhibitors such as the furanocoumarins in grapefruit juice.
- CYP3A4 inducers accelerate drug elimination, reducing its efficacy. These include antiepileptic drugs (carbamazepine, phenytoin, barbiturates), rifampicin, macrolides, glucocorticoids, and herbal products (St. John's wort herb containing hyperforin).
Dosage forms and administration
According to the prescription reference, the drug is available in two forms:
- Tablets of 0.015 g (15 mg).
- Ampoule solution 0.5% — 3 ml.
Dosing regimens:
- Orally (for sleep): 7.5–15 mg at bedtime.
- Premedication: 10–15 mg administered intramuscularly 30 minutes before anesthesia.
Briefly: answers to topical questions
Which drug is used as a specific antidote in midazolam overdose?
Flumazenil is used as a specific antidote in acute midazolam overdose.
- Flumazenil (Anexate) is a competitive antagonist of benzodiazepine receptors.
The drug is administered via intravenous infusion. It is effective in drug-induced respiratory depression and poisoning by classical benzodiazepines, a group to which midazolam belongs (a short-acting benzodiazepine).
What other central nervous system side effects, besides respiratory depression, can midazolam cause?
In addition to respiratory depression, midazolam can cause the following central nervous system side effects:
- Anterograde amnesia — memory loss for events occurring after drug administration (causes short-term amnesia).
- CNS depression in newborns — manifests as a sedative effect, feeding difficulties, and weight loss.
Acute benzodiazepine overdose presents with drowsiness, lethargy, ataxia (coordination impairment), and in severe cases, coma.
What are the absolute contraindications to the use of midazolam?
The cited sources explicitly indicate a contraindication to the use of midazolam: myasthenia gravis.
MIDAzolam — INSTantly GIVES sleep (reflects the short duration of action of 1–5 h and use for rapid sleep onset).
Class and exam questions
Why is midazolam better suited for treating sleep initiation difficulties than diazepam?
Midazolam is a short-acting benzodiazepine (half-life 1–5 h). It quickly facilitates sleep onset, does not cause accumulation, and has virtually no morning hangover effect, unlike long-acting diazepam (40–250 h).
What is the main danger of intravenous midazolam administration?
With intravenous administration, especially when too rapid, there is a high risk of severe respiratory center depression, which can lead to patient respiratory arrest.
How will grapefruit juice affect the action of midazolam?
Furanocoumarins contained in grapefruit juice are dietary inhibitors of the CYP3A4 isoenzyme. They slow down the metabolism of midazolam in the liver, leading to an unpredictable increase in its CNS depressant effect.
What else to study on this topic
- Allosteric modulation of $ ext{GABA}_ ext{A}$ receptors and chloride channels
- Classification of non-narcotic hypnotic agents
- Cytochrome P450 system: substrates, inducers, and inhibitors of CYP3A4
- Premedication and anesthesia induction in anesthesiology
- Z-drugs (zopiclone, zolpidem, zaleplon) and their effect on physiological sleep architecture
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Midazolam" and 5,304 more pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the «Drugs and Prescriptions» section
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.